Table 1.
Incubation of MCF-10F cells with E2-3,4-Q alone or in the presence of NAcCys1
| E2-3,4-Q alone | E2-3,4-Q: NAcCys (1:0.5) | E23,4-Q: NAcCys (1:1) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected Compounds2 | 1 | 10 | 30 | 1 | 10 | 30 | 1 | 10 | 30 |
| pmol/10 million cells | |||||||||
| 4-OHE1(E2) | 4.05 ± 0.32 |
7.79 ± 0.34 |
14.2 ± 1.41 |
2.96 ± 0.24 |
5.79 ± 0.51 |
9.57 ± 1.15 |
1.17 ± 0.26 |
3.07 ± 0.32 |
5.11 ± 0.47 |
| 4-OCH3E1(E2) | 49.7 ± 4.27 |
437 ± 50.9 |
824 ± 120 |
41.9* ± 4.06 |
329* ± 62.3 |
593* ± 59.6 |
32.3* ± 5.48 |
196* ± 28.9 |
302* ± 51.3 |
| 4-OHE1(E2)-2-SG | 0.58 ± 0.05 |
3.13 ± 0.38 |
6.39 ± 0.77 |
0.65 ± 0.06 |
3.75 ± 0.59 |
8.10 ± 1.54 |
0.74* ± 0.06 |
4.36* ± 0.31 |
10.2* ± 1.71 |
| 4-OHE1(E2)-2-Cys | 3.95 ± 0.71 |
8.78 ± 0.56 |
28.1 ± 2.40 |
4.42 ± 0.46 |
10.6* ± 0.72 |
34.7* ± 2.49 |
5.02 ± 0.70 |
12.2* ± 1.28 |
42.1* ± 2.84 |
| 4-OHE1(E2)-2-NAcCys | 1.36 ± 0.28 |
6.37 ± 0.81 |
15.9 ± 2.82 |
1.63 ± 0.29 |
8.15* ± 1.04 |
21.6* ± 1.61 |
1.98* ± 0.26 |
10.3* ± 1.53 |
28.0* ± 3.41 |
| 4-OHE1(E2)-1-N3Ade | 0.39 ± 0.03 |
2.22 ± 0.24 |
5.42 ± 0.60 |
0.34* ± 0.01 |
1.70* ± 0.24 |
3.76* ± 0.26 |
0.28* ± 0.02 |
1.12* ± 0.14 |
1.67* ± 0.35 |
| 4-OHE1(E2)-1-N7Gua | 0.36 ± 0.02 |
2.08 ± 0.18 |
4.97 ± 0.44 |
0.30 ± 0.04 |
1.52 ± 0.39 |
3.50* ± 0.40 |
0.26* ± 0.03 |
0.99* ± 0.13 |
1.55* ± 0.19 |
MCF-10F cells were incubated at 37 °C for 24 h with E2-3,4-Q (1, 10 or 30 µM) alone or in the presence of different ratios of NAcCys.
The compounds were identified and quantified by HPLC-ECD and the adducts were confirmed by UPLC-MS/MS; values are an average of three replicates from three independent pools of medium each from a set of five flasks; ± standard deviation.
The value is significantly different from that in the cell s not treated with NAcCys (p<0.05) as determined by the t-test.